Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
On June 4, Bayer announced that it will complete the acquisition of Monsanto on June 7. The announcement comes after the companies have received all regulatory approvals needed to close the deal. Once the acquisition is complete, Bayer will no longer use the Monsanto name. Our fair value estimates for both Monsanto and Bayer already reflect a 100% probability that the deal closes as proposed. We maintain our $128 per share fair value estimate for wide-moat Monsanto, which is the same as the all-...
The previous high has been passed, the bullish trend is confirmed. The next target is at $128.80. The invalidation level is below $124.20.Arguments :- The support has been reached, it causes the bounce.- The resistance has been passed.- Prices made a new all-time-high, this confirms the strength of the trend.- The moving average is supporting prices.
Le précédent sommet vient d'être franchi, ceci confirme la tendance haussière. Le prochain objectif est à 128,80 $. Le niveau d'invalidation est sous 124,20 $.Arguments :- Le support est atteint, il cause le rebond.- La résistance est dépassée.- Les cours font un nouveau plus haut historique, ce qui témoigne de la force de la tendance.- La moyenne mobile sert de support.
On May 29, the U.S. Department of Justice officially approved Bayer's proposed acquisition of Monsanto. Now that the companies have received all of the major regulatory approvals needed, we expect the deal to close by the end of June. Our fair value estimates for both Monsanto and Bayer already reflect a 100% probability that the deal closes as proposed. As such, we maintain our $128 per share fair value estimate for wide-moat Monsanto, which is the same as the all-cash offer price from Bayer. W...
Unfavorable weather weighed on first-quarter results for many of the agriculture companies we cover, as a delayed start to the U.S. planting season reduced sales across every crop input category. While seed sales should bounce back in the second quarter, we expect less total nitrogen and crop chemicals will be used in 2018 as the late start reduces midseason applications. However, stronger potash demand outside of North America should more than offset stagnant or slightly reduced demand in North...
Monsanto announced that Chairman and Chief Executive Officer Hugh Grant will be stepping down after Bayer’s proposed acquisition of the company closes. Grant, who has worked for Monsanto for over 35 years, has been chairman and CEO since 2003. While details about the timing of the Bayer transaction were not provided, Monsanto said Bayer continues to target closing the deal during the second calendar quarter of 2018, which is consistent with our view that the acquisition will close by the end o...
ST. LOUIS--(BUSINESS WIRE)-- Monsanto Company (NYSE: MON) Chairman and Chief Executive Officer Hugh Grant announced today his intent to leave Monsanto at the closing of the acquisition of Monsanto by Bayer AG. Grant will maintain his position as Chairman and Chief Executive Officer until closing, continuing to focus on leading the company on its top objectives of securing deal approval and delivering on its underlying business priorities. Bayer continues to target closing in the second calendar quarter of 2018. “It has been m...
On April 26, reports indicated that Bayer’s proposed acquisition of Monsanto is on track to receive U.S. Justice Department regulatory approval by the end of May. The approval is the last major regulatory hurdle before the deal can close. Assuming approval is completed by the end of May, we think the deal will likely close by the end of June, which is in line with Bayer management’s most recent timeline. Having already assumed a 100% probability that the deal will close, we maintain our $128...
The previous high has been passed, the bullish trend is confirmed. The next target is at $128.80. The invalidation level is below $114.30.Arguments :- Prices made a new all-time-high, this confirms the strength of the trend.- The rising moving average confirms our opinion.
Le précédent sommet vient d'être franchi, ceci confirme la tendance haussière. Le prochain objectif est à 128,80 $. Le niveau d'invalidation est sous 114,30 $.Arguments :- Les cours font un nouveau plus haut historique, ce qui témoigne de la force de la tendance.- La moyenne mobile, haussière, confirme notre avis.
On April 9, The Wall Street Journal announced that the U.S. Justice Department has approved Bayer’s proposed acquisition of Monsanto. The U.S. was the last major regulatory approval that the companies needed to finalize the deal. We expect the deal to close within the next few months, and as such, we increase our probability that the deal will close as planned to 100% from 75%. The market reacted positively to the news, sending Monsanto shares up nearly 7% to $125.66 at the time of writing. Ou...
Wide-moat Monsanto reported decent second-quarter earnings, as lower corn seed volumes were offset by growth in all other segments. Soybean gross profit increased 7% year on year to $672 million, driven by the company’s Roundup Ready 2 platform. Intacta RR2 Pro soybeans in South America reached our forecast 60 million planted acres, while the Roundup Ready 2 Xtend soybean remains on track to hit our 40 million planted-acre forecast in North America. With no changes to our long-term outlook, we...
ST. LOUIS--(BUSINESS WIRE)-- At the halfway point of its fiscal year, Monsanto Company (NYSE: MON) today highlighted progress related to its FY18 business objectives, including the expected acres of INTACTA RR2 PROTM soybeans in South America and Roundup Ready 2 Xtend® soybeans in the U.S., coupled with the benefits from improved glyphosate pricing. The company also noted that results for its second quarter of fiscal year 2018 represented a solid performance, with as-reported earnings per share of $3.27 and $3.22 in ongoing earnings p...
ST. LOUIS--(BUSINESS WIRE)-- Monsanto Company (NYSE: MON) announced today it will issue the company’s financial results for its fiscal 2018 second quarter via news release on Thursday, April 5, 2018, prior to market open. The news release will focus on the company’s results for the second quarter, future expectations and the pending merger with Bayer. No conference call is scheduled in light of the pending merger with Bayer. Slides related to these results will be posted in the investor section of Monsanto’s website at www.mo...
The previous significant trough has been broken. The trend now is neutral. Should prices move back above this level, we would face a false signal.Arguments :- The major support has been breached.- The resistance has been reached, it causes the fall.- The moving average is capping prices.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.